Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ombline C"'
Autor:
Carinato Hélène, Ombline Conrad, Carole Pflumio, Christian Borel, Manon Voegelin, Alexandre Bernard, Philippe Schultz, Mihaela-Alina Onea, Alain Jung, Sophie Martin, Mickaël Burgy
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Immune checkpoint inhibitors of programmed cell death protein 1 (PD-1) represent a significant breakthrough in treating head and neck squamous cell carcinoma (HNSCC), with long-lasting responses and prolonged survival observed in
Externí odkaz:
https://doaj.org/article/08f90ea39b7d47d7af11c760d913a1cd
Autor:
Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Aude Jehl, Alicia Thiéry, Sébastien Guihard, Romain Vauchelles, Alain C. Jung, Jana Mourtada, Christine Macabre, Sonia Ledrappier, Marie-Pierre Chenard, Mihaela-Alina Onea, Aurélien Danic, Thomas Dourlhes, Claire Thibault, Philippe Schultz, Monique Dontenwill, Sophie Martin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 11178 (2023)
Head and neck squamous cell carcinomas (HNSCCs) are heterogeneous tumors, well known for their frequent relapsing nature. To counter recurrence, biomarkers for early diagnosis, prognosis, or treatment response prediction are urgently needed. miRNAs c
Externí odkaz:
https://doaj.org/article/9853557f254d447ba7097c04c610f09e
Autor:
Aude Jehl, Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Romain Vauchelles, Carole Ronzani, Nelly Etienne-Selloum, Marie-Pierre Chenard, Aurélien Danic, Thomas Dourlhes, Claire Thibault, Philippe Schultz, Monique Dontenwill, Sophie Martin
Publikováno v:
Cells, Vol 12, Iss 5, p 733 (2023)
(1) Background: Epiregulin (EREG) is a ligand of EGFR and ErB4 involved in the development and the progression of various cancers including head and neck squamous cell carcinoma (HNSCC). Its overexpression in HNSCC is correlated with short overall su
Externí odkaz:
https://doaj.org/article/3e9071dc52d54cf3b2ba7636d9de5a6d
Autor:
Mickaël Burgy, Aude Jehl, Ombline Conrad, Sophie Foppolo, Véronique Bruban, Nelly Etienne-Selloum, Alain C. Jung, Murielle Masson, Christine Macabre, Sonia Ledrappier, Hélène Burckel, Carole Mura, Georges Noël, Christian Borel, François Fasquelle, Mihaela-Alina Onea, Marie-Pierre Chenard, Alicia Thiéry, Monique Dontenwill, Sophie Martin
Publikováno v:
Cancers, Vol 13, Iss 12, p 3038 (2021)
The EGFR-targeting antibody cetuximab (CTX) combined with radiotherapy is the only targeted therapy that has been proven effective for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Recurrence arises in 50% of pat
Externí odkaz:
https://doaj.org/article/cf6ec7c6c2d54937afdc4489ee108c8f
Autor:
Mallet A; Département d'oncologie médicale, Institut de cancérologie de l'Ouest - René Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France., Ombline C; Département d'oncologie médicale, Institut de cancérologie de l'Ouest - René Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France., Robert M; Département d'oncologie médicale, Institut de cancérologie de l'Ouest - René Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France., Campone M; Département d'oncologie médicale, Institut de cancérologie de l'Ouest - René Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France., Frenel JS; Département d'oncologie médicale, Institut de cancérologie de l'Ouest - René Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France. Electronic address: jean-sebastien.frenel@ico.unicancer.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2021 Dec; Vol. 108 (11S), pp. 11S19-11S25.